Brand Brain

Voice rules. Asset library. ISI library.

The standing instructions that run on every generation, plus the approved-asset library the engine retrieves from. Edit the brand brain here and every variant in flight learns the new rule.

Voice rules · active
47
12 Compound DT-204-specific
Enforced on every generation
Approved assets
1,240
+86 this month
Photo · b-roll · logo · ISI variant
ISI variants
47
Auto-injected by audience
Long · short · pediatric · pregnancy
Forbidden phrases
184
OPDP + KNSA-internal
Auto-blocked in generation
Brand voice · standing instructions

The rules every generation follows

Encoded once, enforced on every brief. Add a rule here and every variant in flight re-validates against it. Top-25%/bottom-25% performance signal feeds back so the rules tune over time.

✓ Do
  • Use the full brand name 'Compound DT-204' on first reference; 'rilonacept' on second reference if scientific context.
  • Reference the indication explicitly: 'rare cardiology indication,' 'cardiac sarcoidosis,' 'CAPS,' 'DIRA' — not 'inflammatory diseases.'
  • Cite RHAPSODY trial when efficacy claims appear — pull exact stat + footnote text from the approved claims library.
  • Use named team voice ('our team', 'the medical team') or named-physician voice when patients/caregivers narrate.
  • Cost-and-access content names the Co-Pay program by its proper name and links to the Patient Assistance Foundation for government insurance.
  • Pediatric content (12+) carries age-appropriate caregiver fair-balance — not adult ISI.
  • Disease awareness content can run unbranded but must connect to Compound DT-204 within the same campaign on the same audience.
✗ Don't
  • First-person singular ('I', 'my', 'me') — patient/caregiver voice must be team-attributed or named.
  • Comparative claims vs colchicine, NSAIDs, or steroids without head-to-head trial citation.
  • Outcome-guarantee phrases: 'cure', 'guaranteed', 'safest', 'best', '100%'.
  • Adverbs that imply superiority: 'fastest', 'most effective', 'leading'.
  • Off-label suggestions — efficacy mentions tie to FDA-approved indication only.
  • Disease-state pivot to branded claim without ISI proximity (≤ 2 lines or adjacent frame).
  • Consumer-influencer language: 'obsessed', 'spilling', 'the tea', 'glow-up', 'must-have'.
  • Emoji density above 3 per asset — degrades performance across all audiences (data-backed: −8× engagement vs no-emoji).
Approved asset library

Photography · b-roll · logos · diagrams

MLR-cleared, model-released, contractually-cleared. The engine pulls from this library when generating any visual format — never grabs stock or external imagery without explicit override.

Hero photography · patient142
Approved patient photography, model release on file. Ages 35–65, diverse ethnicities, indoor/outdoor variants.
Hero 16:9 · daylight indoor · 32 assetsVertical 9:16 · 28 assetsSquare 1:1 · 18 assets
Hero photography · HCP64
Cardiology + general medicine clinical settings. White-coat optional. RHAPSODY-trial physician portraits cleared for HCP-facing only.
Clinical setting · 24 assetsPortrait · 18 assetsConference / podium · 12 assets
B-roll · clinical context38
Echocardiogram b-roll, ECG traces, cath lab cutaways. Cleared for animated overlays (mechanism-of-action).
ECG 4K · 14 clipsEcho cardiogram · 12 clipsLab b-roll · 12 clips
Logo + lockup library24
Compound DT-204 primary lockup, plus co-brand variants for HCP / patient / pediatric / Co-Pay program.
Primary · 6Co-brand · 12Pediatric · 6
Mechanism-of-action diagrams12
IL-1 cytokine trap mechanism — animated + static. MLR-cleared for HCP audience.
Animated MP4 · 4Static SVG · 6Carousel-ready cuts · 2
Patient story · video library8
Patient testimonial slot · placeholder. Real assets get loaded once Demo Therapeutics shares MLR-cleared, model-released video library.
Slot · awaiting Demo Therapeutics uploadSlot · awaiting Demo Therapeutics uploadSlot · awaiting Demo Therapeutics upload
ISI library · 47 variants

Important Safety Information · auto-injected by audience

Every approved ISI variant — long-form, short-form, pediatric, audio-spec, channel-specific. The engine selects the right ISI for each output automatically based on audience profile + format.

Variant
Chars
Used in
Last review
Long-form · adult patient
2100
Patient sitePatient eBlastLong-form social
Q1 2026
Short-form · adult patient
480
Email bannerDisplay bannerCarousel last frame
Q1 2026
Long-form · HCP
2840
HCP eBlastDetail aidLinkedIn long-form
Q1 2026
Pediatric · caregiver-facing
1620
Pediatric campaignsParent-facing pages
Q1 2026
Audio-only · 60s spec
240
YouTube TrueViewPodcast pre-roll
Q4 2025
Reddit · community thread compatible
320
Reddit promoted postReddit conversation ad
Q1 2026
Cardiac sarcoidosis · adult patient
2180
CS-specific patient content
Q1 2026
Forward thisOne click to the right page for whoever you need to loop in.
Exec one-pager → CMOTrust & Compliance → SecurityEngagement → ProcurementTrack record → SkepticFAQ → AnyoneStart a pilot → Action
What's underneathArchitecture · advisors · published thinking.
Architecture Intelligence · Content Engine · Activation · MeasurementBrain Trust Named advisorsResearch Ephicacy Health · published
Talk to us30 minutes with Maha + Zein. No deck, no sales motion. We answer your questions.
Schedule a demo →hello@ephicacyhealth.com
About Ephicacy Health

We’re building something different.

Ephicacy Healthcare Communications is where the precision of science, the art of storytelling, and intelligent operations converge to reshape healthcare communications — across medical communications, creative advertising, and public relations. OVYN™ is the platform that delivers that work at modern speed.

Let’s Collaborate →
Five expertise pillars
  • Strategic Leadership
  • Medical Communications
  • Creative Advertising
  • Public Relations
  • Customer Experience
  • Data-Driven Imagination
136
Years collective experience
31+
Product launches
4
Global offices
100%
Independent
OVYN · Content Studio for Pharma